Special issue commentary: The changing face of inflammation in the brain

Molecular and Cellular Neuroscience

Volumn 53, Issue , 2013, Pages 1-5

  Anthony, Daniel C ^a   Pitossi, Fernando J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE DISMUTASE;

ACCURACY; ASTROCYTE; CELL ACTIVATION; CELL STRUCTURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENCEPHALITIS; GLIA CELL; HISTOPATHOLOGY; HUMAN; MICROGLIA; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEMANTICS; TUBERCULOUS MENINGITIS;

ANIMALS; BRAIN; ENCEPHALITIS; HUMANS;

EID: 84873292911     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2012.11.005     Document Type: Note

References (50)

1. Andersson P.B., Perry V.H., Gordon S. The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 1991, 42:201-214.
2. Barcia C., Hunot S., Guillemin G.J., Pitossi F. Inflammation and Parkinson's disease. Parkinsons Dis. 2011, 2011:729054.
3. Beers D.R., Henkel J.S., Xiao Q., Zhao W., Wang J., Yen A.A., Siklos L., McKercher S.R., Appel S.H. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16021-16026.
4. Bernardes-Silva M., Anthony D.C., Issekutz A.C., Perry V.H. Recruitment of neutrophils across the blood-brain barrier: the role of E- and P-selectins. J. Cereb. Blood Flow Metab. 2001, 21:1115-1124.
5. Betmouni S., Perry V.H., Gordon J.L. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 1996, 74:1-5.
6. Blasko I., Stampfer-Kountchev M., Robatscher P., Veerhuis R., Eikelenboom P., Grubeck-Loebenstein B. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 2004, 3:169-176.
7. Bolton S.J., Anthony D.C., Perry V.H. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 1998, 86:1245-1257.
8. Broom K., Anthony D., Lowe J., Griffin J., Scott H., Blamire A., Styles P., Perry V., Sibson N. MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes. Neurobiol. Dis. 2007, 26:707-717.
9. Campbell S.J., Meier U., Mardiguian S., Jiang Y., Littleton E.T., Bristow A., Relton J., Connor T.J., Anthony D.C. Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE. Brain Behav. Immun. 2010, 24:738-746.
10. Carman C.V. Mechanisms for transcellular diapedesis: probing and pathfinding by 'invadosome-like protrusions'. J. Cell Sci. 2009, 122:3025-3035.
11. Couch Y., Alvarez-Erviti L., Sibson N.R., Wood M.J., Anthony D.C. The acute inflammatory response to intranigral alpha-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation. J. Neuroinflammation 2011, 8:166.
12. Cunningham C., Wilcockson D.C., Campion S., Lunnon K., Perry V.H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 2005, 25:9275-9284.
13. Davis A.E.M., Campbell S.J., Wilainam P., Anthony D.C. Post-conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: a potential neuroprotective treatment. Eur. J. Neurosci. 2005, 22:2441-2450.
14. Depino A.M. Maternal infection and the offspring brain. J. Neurosci. 2006, 26:7777-7778.
15. Edwards L.J., Sharrack B., Ismail A., Tumani H., Constantinescu C.S. Central inflammation versus peripheral regulation in multiple sclerosis. J. Neurol. 2011, 258:1518-1527.
16. Farooq R.K., Isingrini E., Tanti A., Le Guisquet A.M., Arlicot N., Minier F., Leman S., Chalon S., Belzung C., Camus V. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?. Behav. Brain Res. 2012, 231:130-137.
17. Fedoroff S., Zhai R., Novak J.P. Microglia and astroglia have a common progenitor cell. J. Neurosci. Res. 1997, 50:477-486.
18. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., Samokhvalov I.M., Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
19. Gomez Perdiguero E., Schulz C., Geissmann F. Development and homeostasis of "resident" myeloid cells: the case of the microglia. Glia 2013, 61(1):112-120.
20. Graff J.W., Dickson A.M., Clay G., McCaffrey A.P., Wilson M.E. Identifying functional microRNAs in macrophages with polarized phenotypes. J. Biol. Chem. 2012, 287:21816-21825.
21. Hannestad J., Gallezot J.D., Schafbauer T., Lim K., Kloczynski T., Morris E.D., Carson R.E., Ding Y.S., Cosgrove K.P. Endotoxin-induced systemic inflammation activates microglia: [(11)C]PBR28 positron emission tomography in nonhuman primates. NeuroImage 2012, 63:232-239.
22. Howell O.W., Rundle J.L., Garg A., Komada M., Brophy P.J., Reynolds R. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J. Neuropathol. Exp. Neurol. 2010, 69:1017-1033.
23. Jiang Y., Deacon R., Anthony D., Campbell S. Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases. Neurobiol. Dis. 2008, 32:125-132.
24. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 2009, 29:13435-13444.
25. Letiembre M., Liu Y., Walter S., Hao W., Pfander T., Wrede A., Schulz-Schaeffer W., Fassbender K. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurobiol. Aging 2009, 30:759-768.
26. Lorger M., Felding-Habermann B. Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am. J. Pathol. 2010, 176:2958-2971.
27. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 2006, 177:7303-7311.
28. McColl B.W., Rothwell N.J., Allan S.M. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J. Neurosci. 2007, 27:4403-4412.
29. Mikita J., Dubourdieu-Cassagno N., Deloire M.S., Vekris A., Biran M., Raffard G., Brochet B., Canron M.H., Franconi J.M., Boiziau C., Petry K.G. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 2011, 17:2-15.
30. Mikulkova Z., Praksova P., Stourac P., Bednarik J., Michalek J. Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis. J. Neurol. Sci. 2011, 300:135-141.
31. Murray K.N., Buggey H.F., Denes A., Allan S.M. Systemic immune activation shapes stroke outcome. Mol Cell Neurosci. 2012 Sep 28, doi:pii: S1044-7431(12)00180-7. http://dx.doi.org/10.1016/j.mcn.2012.09.004. [Epub ahead of print].
32. Olah M., Biber K., Vinet J., Boddeke H.W. Microglia phenotype diversity. CNS Neurol. Disord. Drug Targets 2011, 10:108-118.
33. O'Leary D.P., Bhatt L., Woolley J.F., Gough D.R., Wang J.H., Cotter T.G., Redmond H.P. TLR-4 signalling accelerates colon cancer cell adhesion via NF-kappaB mediated transcriptional up-regulation of Nox-1. PLoS One 2012, 7:e44176.
34. Opdenakker G., Van Damme J. Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine 1992, 4:251-258.
35. Palin K., Cunningham C., Forse P., Perry V.H., Platt N. Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration. Neurobiol. Dis. 2008, 30:19-29.
36. Perry V.H. Innate inflammation in Parkinson's disease. Cold Spring Harb. Perspect. Med. 2012, 2.
37. Perry V.H., Cunningham C., Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 2007, 7:161-167.
38. Politis M., Giannetti P., Su P., Turkheimer F., Keihaninejad S., Wu K., Waldman A., Malik O., Matthews P.M., Reynolds R., Nicholas R., Piccini P. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology 2012, 79:523-530.
39. Rivers T.M., Schwentker F.F. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. Exp. Med. 1935, 61:689-701.
40. Rook G. Th1- or Th2-cell commitment during infectious disease: an oversimplification?. Trends Immunol. 2001, 22:481-482.
41. Sibley W.A., Bamford C.R., Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985, 1:1313-1315.
42. Stamatovic S.M., Keep R.F., Andjelkovic A.V. Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr. Neuropharmacol. 2008, 6:179-192.
43. Steiner J., Bielau H., Brisch R., Danos P., Ullrich O., Mawrin C., Bernstein H.G., Bogerts B. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 2008, 42:151-157.
44. Stellwagen D., Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 2006, 440:1054-1059.
45. Thwaites G.E., Schoeman J.F. Update on tuberculosis of the central nervous system: pathogenesis, diagnosis, and treatment. Clin. Chest Med. 2009, 30:745-754. (ix).
46. Trenova A.G., Manova M.G., Kostadinova II., Murdjeva M.A., Hristova D.R., Vasileva T.V., Zahariev Z.I. Clinical and laboratory study of pro-inflammatory and antiinflammatory cytokines in women with multiple sclerosis. Folia. Med. (Plovdiv) 2011, 53:29-35.
47. van Eijk M., Aust G., Brouwer M.S., van Meurs M., Voerman J.S., Dijke I.E., Pouwels W., Sandig I., Wandel E., Aerts J.M., Boot R.G., Laman J.D., Hamann J. Differential expression of the EGF-TM7 family members CD97 and EMR2 in lipid-laden macrophages in atherosclerosis, multiple sclerosis and Gaucher disease. Immunol. Lett. 2010, 129:64-71.
48. Walsh D.T., Perry V.H., Minghetti L. Cyclooxygenase-2 is highly expressed in microglial-like cells in a murine model of prion disease. Glia 2000, 29:392-396.
49. Walsh D.T., Betmouni S., Perry V.H. Absence of detectable IL-1beta production in murine prion disease: a model of chronic neurodegeneration. J. Neuropathol. Exp. Neurol. 2001, 60:173-182.
50. Wyss-Coray T., Rogers J. Inflammation in Alzheimer disease - a brief review of the basic science and clinical literature. Cold Spring Harb. Perspect. Med. 2012, 2:a006346.